) should inspire other manufacturers to develop additional cannabis-derived products through the FDA process.
No takes yet. Share an insight, caveat, or question.
Alice Mead (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: